drugset
drugset / Trial / NCT04814472

Healthy Volunteer Study Comparing Tablet and Oral Solution Formulations

NCT04814472 ↗

Phase 1 Completed 34 enrolled Blade Therapeutics
RandomizedCrossoverOpen-labelTreatment

Summary

A Two-Part, Open-Label, Crossover, Bioavailability Study Comparing Tablet and Oral Solution Formulations of BLD-0409 in Healthy Volunteers

Timeline

Start
2021-05-16
Primary completion
2021-08-17
Completion
2021-11-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Cudetaxestat Small molecule 250 mg Oral
Subject Cudetaxestat Small molecule 500 mg Oral
Subject Cudetaxestat Small molecule 750 mg Oral
Subject Cudetaxestat Small molecule 1000 mg Oral

Indications

No indication recorded.